Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > 2007 BIO International Convention Spotlights Healthcare and Research Advances, Along with Accompanying Industry Policy Challenges

Abstract:
Renowned Parkinson's Disease Patient Advocate Michael J. Fox to Deliver Keynote Address at 2007 BIO International Convention

2007 BIO International Convention Spotlights Healthcare and Research Advances, Along with Accompanying Industry Policy Challenges

Washington, DC | Posted on March 20th, 2007

Global leaders in biotechnology drug development, biomedical research, healthcare policy, nanotechnology and debilitating diseases will gather in Boston, Massachusetts to discuss the recent advances and top challenges facing the industry at the 2007 BIO International Convention. The global event for biotechnology, sponsored by the Biotechnology Industry Organization (BIO), will take place May 6-9, 2007 at the Boston Convention and Exhibition Center.

"The 2007 BIO International Convention will shine the global spotlight on researchers and companies making astonishing advances in biotechnology-based healthcare through innovative research and development," stated Jim Greenwood, president and CEO of BIO. "From an incredible array of conference sessions covering critical topics to our top-notch keynoters to one-on-one presentations, the 2007 BIO International Convention will provide attendees with an unprecedented opportunity to learn about the latest developments in biomedicine along with the challenges that jeopardize continued innovation."

Since the industry's inception, the FDA has approved nearly 300 drugs derived from biotechnology. These approvals have provided treatment for unmet medical needs such as oncology, autoimmune diseases, and infectious diseases, along with many other rare and hard to treat ailments for which there was once no available treatment option. With hundreds of drugs in the pipeline, and thousands more compounds in preclinical investigation, biotechnology continues to offer hope to those whose diseases were once thought to be untreatable.

"Innovation drives our industry, and the last decade has been a testament to the progress that has been achieved in healthcare," noted Greenwood. "The last time the Convention was held in Boston, 120 drugs derived from biotechnology research had been approved. As of the end of 2006, that number was 254. There have been more approvals in those seven years than in all of the industry's prior years combined."

The importance of continued research and innovation will be a key theme when Michael J. Fox, founder of The Michael J. Fox Foundation for Parkinson's Research, delivers the keynote address on May 7. Titled "Driving the Development and Availability of Novel Therapies," Mr. Fox's keynote will address the need for creative approaches to speed translation of the significant investments in research and discovery into meaningful, patient-relevant advances in human health. The discussion will explore strategies and solutions to "de-risk" investment in novel therapeutics for the biotechnology industry and academia alike.

This year's Convention will hold numerous panels, plenary sessions, and keynote speeches focused on a range of healthcare issues. The panel discussions will cover key topics such as bioethics, clinical research and trials, devices and predictive diagnostics, drug discovery and development, manufacturing and regenerative medicine and focus on some of the industry's hot issues including:

* "Cancer Nanotechnology for Early Diagnosis and Therapy"
* "Global Product and Disease Registries: Why and How?"
* "Emerging Opportunities in Molecular Imaging: Sharper Images and Improving Outcomes"

In addition, a Super Session entitled "The Pandemic Flu Syndrome: Are We Ready For the Big One…Or Just Crossing Our Fingers?" will be held on Monday, May 7.

As part of the BIO International Convention's commitment to disease awareness and building relationships between corporations and medical advocacy groups, BIO will sponsor Patient and Health Advocacy displays, which will feature exhibitions by patient advocacy groups who strive to offer information and assistance to those dealing with a multitude of diseases and ailments. These exhibits will be on display the morning of May 7 through the afternoon of May 9.

This year's BIO International Convention, themed "New Ideas. Bold Ventures. Global Benefits," will feature a program packed with more than 200 sessions and speakers focusing on the global aspects of biotechnology, including business development, global health, clinical research/clinical trials, policy, bioethics, devices and diagnostics, biopreparedness, intellectual property/legal, food and agriculture, and industrial and environmental issues. International seminars will spotlight national-level developments from more than 30 countries and regions worldwide. To view the full conference program, please visit http://www.bio2007.org/Attendees/educational_sessions/index.html.

General registration for the BIO International Convention is now available at http://www.bio2007.org/Registration/index.html. Early-bird discounted registrations of more than 30 percent are available until March 23, 2007. For more information about the global event for biotechnology, including housing and program updates, please visit the event homepage at http://www.bio2007.org .

Advance media registration for the BIO International Convention is also available online. Registration is complimentary for credentialed members of the news media. To register, please visit http://www.bio2007.org/Media/index.html . Reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers, college and online publications are strongly encouraged to register in advance by Friday, April 20, 2007.

####

About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology.

Upcoming BIO Events

-- 2007 World Congress on Industrial Biotechnology and Bioprocessing
March 21-24
Orlando, FL

-- BIO International Convention
May 6-9, 2007
Boston, MA

-- BIO VentureForum-East 2007
June 18-20, 2007
Montreal, Canada

-- BIO Mid-America VentureForum 2007
Sep. 24-26, 2007
Milwaukee, WI

For more information, please click here

Contacts:
Biotechnology Industry Organization (BIO)
Erin Reese
202-962-9200
http://www.bio.org

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Events/Classes

IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Cutting-edge nanotechnologies are breaking into industries November 18th, 2016

IEDM: CEO Marie Semeria to Deliver Opening Day Keynote at IEDM 2016; Institute to Present 13 Papers November 17th, 2016

Nanobiotechnology

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Making spintronic neurons sing in unison November 18th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project